227 related articles for article (PubMed ID: 33656660)
21. Real-life experience with chlormethine gel for early-stage mycosis fungoides with emphasis on types and management of cutaneous side-effects
Prag Naveh H; Amitay-Laish I; Zidan O; Leshem YA; Sherman S; Noyman Y; Taieb J; Didkovsky E; Hodak E
J Dermatolog Treat; 2022 Jun; 33(4):2364-2370. PubMed ID: 34427536
[TBL] [Abstract][Full Text] [Related]
22. Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
Geskin LJ; Bagot M; Hodak E; Kim EJ
Dermatol Ther (Heidelb); 2021 Aug; 11(4):1085-1106. PubMed ID: 34021485
[TBL] [Abstract][Full Text] [Related]
23. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences.
Geskin LJ; Angello JT; Bagot M; Guenova E; Nikbakht N; Querfeld C; Scarisbrick JJ
Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):40-47. PubMed ID: 37802679
[TBL] [Abstract][Full Text] [Related]
24. Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.
Alexander-Savino CV; Chung CG; Gilmore ES; Carroll SM; Poligone B
Dermatol Ther (Heidelb); 2022 Mar; 12(3):643-654. PubMed ID: 35122614
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
26. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
Trager MH; Chen C; Husain S; Geskin LJ
J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
[TBL] [Abstract][Full Text] [Related]
27. Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study.
Querfeld C; Nelson WW; Gor D; Pashos CL; Doan QV; Turini M; Angello JT; Geskin LJ
Dermatol Ther (Heidelb); 2022 Dec; 12(12):2781-2795. PubMed ID: 36284059
[TBL] [Abstract][Full Text] [Related]
28. Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study.
Querfeld C; Kim YH; Guitart J; Scarisbrick J; Quaglino P
J Am Acad Dermatol; 2022 Jul; 87(1):209-211. PubMed ID: 34333079
[No Abstract] [Full Text] [Related]
29. The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region).
Assaf C; Booken N; Dippel E; Guenova E; Jonak C; Klemke CD; Nicolay JP; Schlaak M; Wobser M; Trautinger F
J Dtsch Dermatol Ges; 2022 May; 20(5):579-586. PubMed ID: 35429108
[TBL] [Abstract][Full Text] [Related]
30. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
31. Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Querfeld C; Geskin LJ; Kim EJ; Scarisbrick JJ; Quaglino P; Papadavid E; Angello JT; Ortiz-Romero PL
J Invest Dermatol; 2021 Jun; 141(6):1601-1604.e2. PubMed ID: 33347924
[No Abstract] [Full Text] [Related]
32. Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases.
Ardigò M; Nikbakht N; Teoli M; Gleason L; Crisan L; Querfeld C
Front Med (Lausanne); 2023; 10():1308491. PubMed ID: 38274457
[TBL] [Abstract][Full Text] [Related]
33. Topical nitrogen mustard in mycosis fungoides.
Zachariae H
Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.
Vonderheid EC; Tan ET; Kantor AF; Shrager L; Micaily B; Van Scott EJ
J Am Acad Dermatol; 1989 Mar; 20(3):416-28. PubMed ID: 2537348
[TBL] [Abstract][Full Text] [Related]
35. Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides.
MacArthur KM; Jariwala N; Kim EJ; Rook AH
Acta Derm Venereol; 2017 Mar; 97(3):373-374. PubMed ID: 27868149
[No Abstract] [Full Text] [Related]
36. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
[TBL] [Abstract][Full Text] [Related]
37. Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
Newman JM; Rindler JM; Bergfeld WF; Brydon JK
J Am Acad Dermatol; 1997 Jan; 36(1):112-4. PubMed ID: 8996276
[No Abstract] [Full Text] [Related]
38. Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides.
Shalabi D; Kartan S; O'Donnell M; Zaya R; Zhan T; Shi W; Alpdogan O; Porcu P; Nikbakht N
J Dermatol Sci; 2020 May; 98(2):98-101. PubMed ID: 32362434
[TBL] [Abstract][Full Text] [Related]
39. An Elderly Man With New Skin Plaques Consistent With Cutaneous T-Cell Lymphoma.
Rubio-González B; Zain J; Rosen ST; Querfeld C
Oncology (Williston Park); 2016 Oct; 30(10):908-13. PubMed ID: 27744647
[No Abstract] [Full Text] [Related]
40. Management of chlormethine gel treatment in mycosis fungoides patients in two German skin lymphoma centers.
Wehkamp U; Jost M; Gosmann J; Grote U; Bernard M; Stadler R
J Dtsch Dermatol Ges; 2021 Jul; 19(7):1057-1059. PubMed ID: 33942508
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
